copyright © 2018 the indian express [p] ltd. all rights reserved
. 18 may, 2018, 09:28 | author: denise dawson
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.